Maria F. Coakley
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Circulating tumour DNA assays in focus: highlights from ASCO 2025 for clinicians.
Journal: BJC reports
Published: August 16, 2025
Association of post-operative ctDNA detection with outcomes of patients with early breast cancers.
Journal: ESMO open
Published: January 17, 2024
Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 11, 2023
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: July 14, 2022
Impact of timing of adjuvant chemothapy for early breast cancer: the Royal Marsden Hospital experience.
Journal: British journal of cancer
Published: July 06, 2020
Survival following allogeneic transplant in patients with myelofibrosis.
Journal: Blood advances
Published: October 10, 2019
Molecular Residual Disease and Adjuvant Trial Design in Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 14, 2019
BRCA1/2 germline testing in non-mucinous epithelial ovarian carcinoma: changing international practice and implications for service provision.
Journal: European journal of human genetics : EJHG
Published: October 21, 2016
Discrepancies of applying primary myelofibrosis prognostic scores for patients with post polycythemia vera/essential thrombocytosis myelofibrosis.
Journal: Haematologica
Published: June 30, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026